ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Zhihang Xu
Matched on OpenAlex author ID A5044280846. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers · 2026: 1 paper
Papers 5
- Supervising the recurrence of pancreatic ductal adenocarcinoma using CtDNA-based MIR129-2 methylation detection. First author DOI 10.1097/js9.0000000000003449↗
- The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in Pancreatic Cancer. Co-author DOI 10.1002/advs.202500806↗
- Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pan… Co-author DOI 10.1097/js9.0000000000002733↗
- Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer. Co-author DOI 10.1200/jco.24.00287↗
- A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2022.188751↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ning Pu · 4 shared papers, 2025–2026 · strength 0.82
- Paper Supervising the recurrence of pancreatic ductal adenocarcinoma using CtDNA-based MIR129-2 methylation detection. DOI 10.1097/js9.0000000000003449↗
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Wenquan Wang · 3 shared papers, 2022–2026 · strength 0.67
- Paper Supervising the recurrence of pancreatic ductal adenocarcinoma using CtDNA-based MIR129-2 methylation detection. DOI 10.1097/js9.0000000000003449↗
- Paper A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer. DOI 10.1016/j.bbcan.2022.188751↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Taochen He · 3 shared papers, 2025–2026 · strength 0.66
- Paper Supervising the recurrence of pancreatic ductal adenocarcinoma using CtDNA-based MIR129-2 methylation detection. DOI 10.1097/js9.0000000000003449↗
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Yaolin Xu · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Jiande Han · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Hanlin Yin · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Haibo Wang · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Qiangda Chen · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Jun Yu · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Wenhui Lou · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Yun Jin · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Wenchuan Wu · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Liang Liu · 2 shared papers, 2022–2025 · strength 0.39
- Liang Liu · 1 shared paper, 2026 · strength 0.24
- Huijuan Li · 1 shared paper, 2026 · strength 0.24
- Wenhui Lou · 1 shared paper, 2022 · strength 0.22
- Liang Liu · 1 shared paper, 2025 · strength 0.20
- Yanfei An · 1 shared paper, 2025 · strength 0.20
- Zipeng Lu · 1 shared paper, 2025 · strength 0.17
- Lingdi Yin · 1 shared paper, 2025 · strength 0.17
- Jian‐Min Chen · 1 shared paper, 2025 · strength 0.17
- Wentao Gao · 1 shared paper, 2025 · strength 0.17
- Yunpeng Peng · 1 shared paper, 2025 · strength 0.17
- Jishu Wei · 1 shared paper, 2025 · strength 0.17
- Yi Miao · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.